Atezolizumab in Advanced Non-small Cell Lung Cancer With Rare Histologies (CHANCE Trial)
Clinical trial NCT03976518 · COMPLETED
Trial details
- NCT number
- NCT03976518
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2024-02-12
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.